Anthony H Nguyen

Array ( [id] => 5787004 [patent_doc_number] => 20020160379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Gapped 2\' modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/951052 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13564 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160379.pdf [firstpage_image] =>[orig_patent_app_number] => 09951052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394423 [patent_doc_number] => 20040038399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Chimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotides' [patent_app_type] => new [patent_app_number] => 10/363768 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8616 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038399.pdf [firstpage_image] =>[orig_patent_app_number] => 10363768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715902 [patent_doc_number] => 20030027250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing' [patent_app_type] => new [patent_app_number] => 09/941492 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 30674 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027250.pdf [firstpage_image] =>[orig_patent_app_number] => 09941492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6689063 [patent_doc_number] => 20030032788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Methods of inhibiting alcohol consumption' [patent_app_type] => new [patent_app_number] => 09/932300 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25041 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032788.pdf [firstpage_image] =>[orig_patent_app_number] => 09932300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534253 [patent_doc_number] => 07888324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Antisense modulation of apolipoprotein B expression' [patent_app_type] => utility [patent_app_number] => 09/920033 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888324.pdf [firstpage_image] =>[orig_patent_app_number] => 09920033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640368 [patent_doc_number] => 06395545 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Antisense modulation of inhibitor-kappa B kinase-alpha expression' [patent_app_type] => B1 [patent_app_number] => 09/856074 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22230 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395545.pdf [firstpage_image] =>[orig_patent_app_number] => 09856074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720139 [patent_doc_number] => 07049290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon' [patent_app_type] => utility [patent_app_number] => 09/915543 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 19 [patent_no_of_words] => 14043 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049290.pdf [firstpage_image] =>[orig_patent_app_number] => 09915543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342250 [patent_doc_number] => 06590078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-08 [patent_title] => 'DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi' [patent_app_type] => B2 [patent_app_number] => 09/912733 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 25 [patent_no_of_words] => 20013 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590078.pdf [firstpage_image] =>[orig_patent_app_number] => 09912733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343915 [patent_doc_number] => 20020035083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'CRF2 ligands in combination therapy' [patent_app_type] => new [patent_app_number] => 09/908825 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9358 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035083.pdf [firstpage_image] =>[orig_patent_app_number] => 09908825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870588 [patent_doc_number] => 20030083278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of CD40 ligand expression' [patent_app_type] => new [patent_app_number] => 09/909595 [patent_app_country] => US [patent_app_date] => 2001-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26140 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083278.pdf [firstpage_image] =>[orig_patent_app_number] => 09909595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1012559 [patent_doc_number] => 06897030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-24 [patent_title] => 'Immunoassays for human brain natriuretic peptide' [patent_app_type] => utility [patent_app_number] => 09/902517 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11459 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897030.pdf [firstpage_image] =>[orig_patent_app_number] => 09902517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 184604 [patent_doc_number] => 07648695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Medicaments for chemotherapeutic treatment of disease' [patent_app_type] => utility [patent_app_number] => 09/900355 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7119 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648695.pdf [firstpage_image] =>[orig_patent_app_number] => 09900355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951330 [patent_doc_number] => 20020006641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Increasing production of proteins in gram-positive microorganisms' [patent_app_type] => new [patent_app_number] => 09/899482 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10641 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006641.pdf [firstpage_image] =>[orig_patent_app_number] => 09899482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1334985 [patent_doc_number] => 06593088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Reversible photocoupling nucleic acid and phosphoroamidite' [patent_app_type] => B1 [patent_app_number] => 09/830401 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1625 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593088.pdf [firstpage_image] =>[orig_patent_app_number] => 09830401 [rel_patent_id] =>[rel_patent_doc_number] =>)